Sodium Fluoride — the INCI name familiar to every formulator of toothpaste and mouthwash — has been placed under the spotlight by COSlaw.eu, the platform guiding industry professionals through EU cosmetics regulation.

The ingredient is one of the most widely used actives in oral care products sold across the European Union. It appears in the EU Cosmetics Regulation's annexes as a substance subject to strict concentration limits and specific permitted product categories, meaning formulators cannot treat it as a free-for-all input. Any product development work involving Sodium Fluoride requires close attention to the current annex entries, the maximum permitted concentrations, and the mandatory labelling warnings that attach to fluoride-containing products.

For regulatory and compliance teams, the significance of the COSlaw.eu spotlight lies in consolidation. Ingredients with long regulatory histories tend to accumulate amendments, adapted technical annexes and periodic reviews by the Scientific Committee on Consumer Safety (SCCS). Professionals responsible for product information files (PIFs) and safety assessments must verify that the version of the annex text they work from remains current, because a superseded limit or labelling phrase creates compliance exposure at the level of both the responsible person and national market surveillance authorities.

The spotlight also has practical weight for buyers and procurement teams sourcing fluoride salts. Supplier documentation — including specifications, impurity profiles and certificates of analysis — feeds directly into the safety assessment. Any revision of the regulatory treatment of Sodium Fluoride would ripple into supplier qualification processes and raw material specifications across the oral care category.

Treatment providers and dental-focused brands should note that fluoride remains a category where consumer perception and regulatory status occasionally diverge. While fluoride-free formulations have carved out shelf space, the regulatory framework continues to treat Sodium Fluoride as an approved, restricted active — a status that the COSlaw.eu review reinforces for professional readers.

What to watch next: any future SCCS opinion or Commission amendment touching fluoride limits or permitted categories would trigger PIF updates across the oral care sector, so compliance teams should monitor the EU official journal and SCCS meeting agendas in the coming quarters.